Implement the mental health policy and the establish the WHO Collaborating Centre on Addictions
Product/Service
Technical support to respond to substance-related disorders/addictive behaviours
Jan 01, 2026Dec 31, 2028
%
GPW
GPW 14
GPW Output
4.1.1 WHO develops evidence-based policies and supports the implementation, scale-up and measurement of best buys and other actions to strengthen person-centered prevention, control and management of noncommunicable diseases
GPW Output Indicator
Country has evidence-based national guidelines/protocols/standards aligned with WHO guidance for the management of major NCDs through a primary care approach
GPW Outcome
4.1 Equity in access to quality services improved for noncommunicable diseases, mental health conditions and communicable diseases, while addressing antimicrobial resistance
GPW Outcome Indicator
Service coverage for people with mental health and neurological conditions
Phase 5 Output
3.2 - Equity in access to quality services improved
Phase 5 Objective
SO3 - Accelerated progress towards universal access to basic health services, to achieve UHC.
Ongoing
Assist the NRA (AMMPS) in achieving maturity level 3 through WHO GBT tool
Assist the NRA (AMMPS) in achieving maturity level 3 through WHO GBT tool
Product/Service
Technical support to strengthen regulatory systems at national/regional levels
Jan 01, 2026Dec 31, 2028
%
GPW
GPW 14
GPW Output
3.2.3 WHO supports countries to implement measures for better access to, and use of, safe, effective and quality-assured health products
GPW Output Indicator
A list of essential medicines (or reimbursed medicines) developed centrally, updated within the last 5 years, and grounded in the concept of the WHO Model List of Essential Medicines
GPW Outcome
3.2 Health and care workforce, health financing and access to quality-assured health products substantially improved
GPW Outcome Indicator
Access to Health Product Index
Phase 5 Output
1.4 - Health products
Phase 5 Objective
SO1 - Reinforced support to Universal Health Coverage.
Ongoing
Develop the national blood policy and strategy for the Moroccan agency for blood and its derivatives
Develop the national blood policy and strategy for the Moroccan agency for blood and its derivatives
Product/Service
Guidance to improve blood product availability, accessibility, quality, safety
Jan 01, 2026Dec 31, 2028
%
GPW
GPW 14
GPW Output
3.2.3 WHO supports countries to implement measures for better access to, and use of, safe, effective and quality-assured health products
GPW Output Indicator
A list of essential medicines (or reimbursed medicines) developed centrally, updated within the last 5 years, and grounded in the concept of the WHO Model List of Essential Medicines
GPW Outcome
3.2 Health and care workforce, health financing and access to quality-assured health products substantially improved
GPW Outcome Indicator
Access to Health Product Index
Phase 5 Output
1.4 - Health products
Phase 5 Objective
SO1 - Reinforced support to Universal Health Coverage.
Ongoing
Train Rapid Response Teams (RRTs) and implement simulation exercises for public health emergencies
Assess the national health financing strategy for normal and emergency situations and its update in accordance with the health system reform guidance
Product/Service
Technical support to strengthen policies improving financial protection
Jan 01, 2026Dec 31, 2028
%
GPW
GPW 14
GPW Output
4.3.1 WHO provides guidance and technical assistance and strengthens capacity to track health expenditures at the system level to monitor financial hardship and financial barriers to access and inform decision-making for financial and social health p
GPW Output Indicator
Updated analysis of financial protection utilized to inform national health policies towards Universal Health Coverage, developed with WHO support
GPW Outcome
4.3 Financial protection improved by reducing financial barriers and out-of-pocket health expenditures, especially for the most vulnerable
GPW Outcome Indicator
Out-of-pocket payment as a share of current health expenditure
Phase 5 Output
1.2 - Health financing and financial protection improved
Phase 5 Objective
SO1 - Reinforced support to Universal Health Coverage.